XClose

Towers Lab

Home
Menu

News 2021

'Evolution of enhanced innate immune evasion by SARS-CoV-2' is published in Nature, Dec 2021

Thorne el al, Nature 2021

AK Reuschl, Lucy Thorne and Lorena Alvarez-Zuliana researching SARS-CoV-2, Jan 2021

Lucy and AK's work with Lorena and Mehdi Bouhaddou from the Krogen Lab on the enhanced evasion of the inante immune system by the Alpha varient when compared to the first wave strains is published in Nature.


Times Radio interviewed Greg as we move with Omicron into the New Year, Dec 2021

Times Radio, Dec 2021

 

 


SARS-CoV-2 Q&A with Greg, Maddy and Mala, and hosted by Richard, Dec 2021

MediaCentral Widget Placeholderhttps://mediacentral.ucl.ac.uk/Player/6DJa0Fg9

 

 

 

Prof Richard Milne interviews Prof Mala Maini, Prof Maddy Noursadeghi and Prof Greg Towers about SARS-CoV-2, Dec 2021

Professor Richard Milne hosts a discussion about SARS-CoV-2 and COVID19 with Greg and colleagues Professors Mala Maini and Maddy Noursadeghi both of whom work on COVID19 immunology for the UCL infection students. They discuss what we’ve learned about how CoV2 interacts with your immune system to give asymptomatic infection or drive disease.


NTV Broadcasting interviewed Greg for their Saturday Night Show, Dec 2021

NTV logo

Prof Greg Towers interviewed by NTV, Dec 2021

Russian TV station NTV interviewed Greg for his opinion of Omicron and vaccination.


Omicron and Christmas - Greg was interviewed with Professor Chris Smith from Cambridge University by LBC's Eddie Mair, Dec 2021

Eddie Mair interviewed Greg, Dec 2021

 


Welcome to the lab to our two new PhD students! Sept, 2021

Lydia Newton and Kate Morling start their PhDs, Sept 2021

 

Lydia and Kate have joined the Towers lab to complete their PhDs. Lydia is on the UCL Birkbeck MRC DTP in colaboration with Professor Flemming Hansen (Institute of Structural and Molecular Biology) and Kate is on the ISMB 4 year Interdisciplinary PhD Programme in Structural, Computational and Chemical Biology in collaboration with Professor David Selwood.


Steve has produced some epic images of SARS-CoV-2 infection, Sept 2021

Calu3 cells infected with SARS-CoV-2. Image courtsey of S. Gschmeissner. Copyright

Caco2 cells infected with SARS-CoV-2. Image courtsey of S. Gschmeissner. Copyright

Dr Steve Gschmeissner, who we collaborate with on SEM imaging, has taken some great pictures of Giulia's SARS-CoV-2 infected VeroE6-tmprss, CaCo-2, and Calu-3 cells


NTV returned to interview Greg for a COVID update, Aug 2021

NTV logo

Prof Greg Towers being interviewed by NTV, Aug 2021

Russian TV station NTV re-visited the lab for an update from Greg on COVID and vaccination.


We welcome our new Postdocs, July 2021

Towers lab has four new Postdocs - Dara, Jas, Ying and Giulia, June 2021

 

We welcome Dara, Jas, Ying and Giulia to the lab. Looking forward to working with you in these exciting times.


Dr Steve Gschmeissner has been awarded the Lennart Nilsson Award, June 2021

Lennart Nilsson Award, Karolinska Institutet

Dr Steve Gschmeissner

Coloured scanning electron micrograph of ovarian cancer cells. Picture courtsey of Stephen Gschmeissner

Steve has been awarded the 2021 Lennart Nilsson Award in recognition of his skillful use of the SEM to reveal the minute world of the cell and his many years of work across various fields including virology and cancer research.

 


Greg consults to the WHO, June 2021

WHO logo

 

Greg presented 'EVOLUTION OF ENHANCED INNATE IMMUNE EVASION BY SARS-CoV-2 UK B.1.1.7 VARIANT' to WHO with Prof Nevan Krogan from the University of California, San Fransisco

 


Rich is moving on from the Towers lab, June 2021

Rich's leaving gifts, June 2021

Dr Rich Miles (photo by Kelvin Vine)

After 8 years, one PhD and a Postdoc, Rich is moving on to a new career in law. We wish him luck and look forward to catching up.


'Evolution of enhanced innate immune evasion by the SARS-CoV-2 B.1.1.7 UK variant' is on BioRxiv and The New York Times has been talking to Greg and Nevan Krogan, June 2021

Lucy, Matt, Lorena and AK, June 2021

 

Our latest paper with collaborators including the Jolly and Krogan labs, demonstrating our work on how the Alpha variant evades early immune responses is on BioRxiv and it has attracted the attention of the New York Times.


Sophie is moving on from the Towers lab to join the MRC, June 2021

Sophie and her leaving gifts, June 2021

 

Sophie has left to join the MRC's translational technology unit. We are sorry to see her go but look forward to plenty of coffees and beers while keeping in touch.


We said 'Goodbye' to Ethel who has gone on to a position with the NHS, May 2021

Ethel's leaving drinks at the Exmouth Arms. Heena, Sophie, Mao, Ethel, Morten, Rob, Jas, Ying, Dejan, AK, Lucy, Clare and Joe enjoy a long awaited drink, May 2021

Ethel's leaving drinks at the Exmouth Arns. Sophie, Mao, Morten, Dejan Jane and Heena, May 2021k, May 2021

We waived a fond fairwell to Ethel as she left to persue a career with CQUIN in the NHS. We wrapped up warm to enjoy our first socially distanced drink in the pub for some time!


Lucy, AK, Lorena and Matt's paper is published in The Embo Journal, May 2021

Dr Lucy Thorne investigating SARS-CoV-2, May 2020 (photo courtesy of Nick David www.nickdavid.co.uk)

Figure 7 rfom Thorne et al, Embo, June 2021

All the hours and hard work in the cat3 lab have paid off. Lucy, Lorena, AK and Matt's paper is published in The Embo Journal. SARS-CoV-2 sensing by RIG-I and MDA5 links epithelial infection to macrophage inflammation.


Variants of concern and the Route out of lockdown, Greg is interviewed by Andrew Caslte on LBC, April 2021

Greg is interviewed on LBC about variants and travel quarantine, April 2021

 

Greg discusses how concerned we should be about variants and how feasible it is for all travelers from abroard to quarantine with Andrew Castle at LBC


Ilaria has left to take up a position in Italy, March 2021

Dr Ilaria Nisoli (photo by Kelvin Vine)

Ilaria's leaving gift, March 2021

Ilaria has gone on to work with Prof Piero Carninci at the Human Technopole in Milan. We are sorry to say 'Goodbye!' from such a distance after so many years at UCL. We wish her well in Italy and hope to catch up soon.


Emerging Variants, The Red Queen Theory and Nextstrain. Greg is interviewed by Metro, March 2021

METRO Logo

 

Greg spoke to Metro about emerging variants of COVID and their spread around the globe. He discusses the Red Queen theory of an arms race between virus and host immune response to explain the drive behind mutations.


ABC News joined Lucy and AK as they met with Lorena and the rest of our American collaborators on Teams, March 2021

ABC News joined the Towers and Krogen labs at their weekly meeting, March 2021

Lorena, Lucy and AK at Krogan/Towers lab meeting recorded by ABC News, March 2021

ABC news joined the experiment planning with our latest COVID collaboration with the Krogan lab at UCSF


Chris van Tulleken interviewed Greg for 'The Jump' on Radio 4, March 2021

Chris van Tulleken presents 'The Jump' on Radio 4, March 2021

 

Human behavoirs are causing pandemics. Chris van Tulleken interviews experts from across the virology field to investigate why viruses jump host species and the behavoirs humans have that increase the risk of this. In episode 3 he interviews Greg about HIV, its history of jumping and if we know why it sometimes becomes pandemic. Listen to 'The Jump' on Radio 4.


Brazil's COVID varient's spread accross Europe mapped - Metro interviewed Greg, March 2021

METRO Logo

 

Greg was interviewed by Metro about the COVID varient first found in Brazil's spread across Europe. The Genie is out of the bottle.


Doug has returned to Clinical Training. But he'll be back! Feb 2021

lm-doug-fink-image1-800x480

 

We said 'Goodbye!' to Doug who has gone on to the next stage of his clinical career. We hope to see him back later in the year.


WIRED magazine has been chatting with Greg, Feb 2021

WIRED logo

 

The safety of UV-C wands and their effectivity can we be sure they are living up to their claims? And our expectations of summer in 2021, the possibility of travel, sporting, and music events and the role vaccine will play.


Will the Kent Variant Sweep the world? Greg discusses this and more on LBC, Feb 2021

Prof Greg Towers  is interviewed by Tom Swarbrick about the Kent varient of SARS-CoV-2 on LBC, Feb 2021

 

Greg was interviewed by Tom Swarbrick on LBC about the SARS-CoV-2 Kent varient, why varients emerge and how likely they are to sweep the world. Listen to his interview on LBC here.


The Express picks up the LBC interview on the Kent Variant, Feb 2021

The Express reports on Greg's interview on LBC about the Kent Variant, Feb 2021

 


Russian TV station interviewed Greg about COVID Research, Feb 2021

NTV logo

Greg and his NTV interviewer, Dec 2021

Russian TV statoin NTV is keen to hear about the latest SARS-CoV-2 research


iNews Reports on our Published Work on Aplidin, Jan 2021

Alpidin article in iNews, Jan 2021

 

Go to the iNews site to read their article.


'Host-directed therapies against early-lineage SARS-CoV-2 retain efficacy against B.1.1.7 variant' published on BioRxiv, Jan 2021

AK Reuschl, Lucy Thorne and Lorena Alvarez-Zuliana researching SARS-CoV-2, Jan 2021

Reuschl et al Host-directed therapies against early-lineage SARS-CoV-2 retain efficacy against B.1.1.7 variant, Jan 2021

The first study of the full-length B.1.1.7 variant virus, we find two host-directed drugs to possess similar antiviral activity against both the early-lineage SARS-CoV-2 and the B.1.1.7 variant. Read the results of Lucy, AK and Lorena's long hours and hard work alongside the Krogan lab at UCSF.


The Towers lab is part of the ‘G2P-UK’ National Virology Consortium’, Jan 2021

Pipetting. Image courtesy of Nick David www.nickdavid.co.uk

Prof Greg Towers

‘G2P-UK’ National Virology Consortium’ unites 10 UK Institutions to investigate the threats of new SARS-CoV-2 variants. Read about the Consortium and the UCL team, lead by Greg Towers, in 'Threats of new SARS-CoV-2 variants focus of UK-wide study'